Utah Colorado Biotech Networks
Advertise With Biotech Networks
  • Home
  • About
  • News
    • All News
    • UCBN Trending News
  • Jobs
    • All Jobs
    • Submit a Job
  • Advertise
  • BN Connect
    • BN Connect
    • About Biotech Networks Connect
  • Subscribe
  • Contact
News Ticker
  • [ August 21, 2026 ] Part-time Open Rank Research Services Laboratory Services Professional (Entry – Intermediate) (0.5 FTE) – Aurora, CO Jobs
  • [ August 20, 2026 ] Oncology Account Executive – Salt Lake City, UT Jobs
  • [ August 20, 2026 ] Bucked Up® Launches Hunt: Orange Cream, a Limited-Edition Flavor Built to Fuel Your Hunt News
  • [ August 20, 2026 ] New NCCI data analysis confirms Pinnacol Assurance has fastest, most accurate claims handling in Colorado News
  • [ August 20, 2026 ] Engineer 2 – Human Factors – Lakewood, CO Jobs
HomeNewsDaVita lowers forecast after lower treatment volume, labor challenges

DaVita lowers forecast after lower treatment volume, labor challenges

October 28, 2022 UCBN News Comments Off on DaVita lowers forecast after lower treatment volume, labor challenges

Company leaders say the Covid-19 pandemic is still complicating patient treatment patterns
Click here to view original post

  • colorado
  • CONews
Previous

Weekly Policy Update: Recent State Budget Forecasts

Next

PCR Account Executive – Absolute Diagnostics – Denver, CO

Related Articles

News

Zynex Submits FDA Application for Its NiCO Laser Pulse Oximeter

May 12, 2025 UCBN News, Syndication Comments Off on Zynex Submits FDA Application for Its NiCO Laser Pulse Oximeter

ENGLEWOOD, Colo., May 12, 2025 /PRNewswire/ — Zynex, Inc. (NASDAQ: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain management, rehabilitation, and patient monitoring, today announced […]

News

Medtronic partners with CU campuses to develop future medical technology

January 22, 2026 UCBN News, Syndication Comments Off on Medtronic partners with CU campuses to develop future medical technology

The medical device giant is putting an initial $250,000 toward innovation at University of Colorado campuses. Click here to view original post Click Here to Publish/Feature Your Company or Product News with Biotech Networks

No Picture
News

Edgewise Receives U.S. FDA Fast Track Designation for EDG-5506 for the Treatment of Duchenne Muscular Dystrophy (Duchenne)

February 13, 2024 UCBN News, Syndication Comments Off on Edgewise Receives U.S. FDA Fast Track Designation for EDG-5506 for the Treatment of Duchenne Muscular Dystrophy (Duchenne)

BOULDER, Colo.–(BUSINESS WIRE)–Edgewise Therapeutics, Inc., (Nasdaq: EWTX), a leading muscle disease biopharmaceutical company, today announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track designation for EDG-5506 for the treatment of Duchenne. […]

Advertise With Biotech Networks

Copyright © 2026 Biotech Networks

Get Weekly/Trending/Daily News & Jobs Delivered to Your Inbox